Yixin Liu Selected Research

Inflammation (Inflammations)

3/2024	Single-cell RNA sequencing reveals the immune features and viral tropism in the central nervous system of mice infected with Japanese encephalitis virus.
9/2023	Puerarin inhibits inflammation and lipid accumulation in alcoholic liver disease through regulating MMP8.
1/2023	Longitudinal Gut Microbiota Dysbiosis Underlies Olanzapine-Induced Weight Gain.
1/2023	Aryl hydrocarbon receptor dependent anti-inflammation and neuroprotective effects of tryptophan metabolites on retinal ischemia/reperfusion injury.
11/2022	Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury.
9/2022	Regulatory Effect of Isomaltodextrin on a High-Fat Diet Mouse Model with LPS-Induced Low-Grade Chronic Inflammation.
1/2022	Gut Microbiota Interact With the Brain Through Systemic Chronic Inflammation: Implications on Neuroinflammation, Neurodegeneration, and Aging.
1/2022	Stress and cancer: The mechanisms of immune dysregulation and management.
12/2021	The immunology and immunotherapy for COVID-19.
1/2020	Plasma exosomal miRNAs involved in endothelial injury in microscopic polyangiitis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yixin Liu Research Topics

Disease

28	Neoplasms (Cancer) 04/2024 - 02/2010
10	Inflammation (Inflammations) 03/2024 - 01/2020
7	Neoplasm Metastasis (Metastasis) 04/2024 - 02/2010
6	Infections 03/2024 - 10/2012
5	Adenocarcinoma of Lung 12/2022 - 01/2018
4	Carcinoma (Carcinomatosis) 04/2024 - 01/2018
4	Breast Neoplasms (Breast Cancer) 01/2023 - 02/2010
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2023 - 11/2019
3	Stomach Neoplasms (Stomach Cancer) 01/2023 - 03/2015
3	Fibrosis (Cirrhosis) 07/2022 - 09/2011
3	Rheumatoid Arthritis 07/2019 - 09/2018
2	Sarcopenia 12/2023 - 01/2021
2	Body Weight (Weight, Body) 01/2023 - 01/2022
2	Reperfusion Injury 01/2023 - 11/2022
2	Glaucoma 01/2023 - 01/2023
2	Ischemia 01/2023 - 11/2022
2	Multiple Endocrine Neoplasia Type 2a (MEN 2) 10/2022 - 12/2020
2	Thyroid Neoplasms (Thyroid Cancer) 10/2022 - 01/2021
2	COVID-19 12/2021 - 10/2021
2	Carcinogenesis 01/2021 - 01/2018
2	Atherosclerosis 12/2020 - 10/2014
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020 - 03/2012
2	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 03/2018
1	Neuralgia (Stump Neuralgia) 05/2024
1	Japanese Encephalitis 03/2024
1	Ovarian Epithelial Carcinoma 02/2024
1	Colorectal Neoplasms (Colorectal Cancer) 11/2023
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 09/2023
1	Exanthema (Rash) 07/2023
1	Dyslipidemias (Dyslipidemia) 07/2023
1	Dizziness (Lightheadedness) 07/2023
1	Ascites 04/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2023
1	Obesity 01/2023
1	Pre-Eclampsia (Preeclampsia) 01/2023
1	Blindness (Hysterical Blindness) 01/2023

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 11/2023 - 09/2011
11	Biomarkers (Surrogate Marker)IBA 03/2024 - 02/2010
5	Messenger RNA (mRNA)IBA 02/2024 - 10/2012
4	Long Noncoding RNAIBA 02/2024 - 01/2019
4	LipidsIBA 09/2023 - 01/2022
4	Conditioned Culture MediaIBA 01/2023 - 01/2014
4	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2017
3	LigandsIBA 03/2024 - 02/2010
3	RNA (Ribonucleic Acid)IBA 03/2024 - 07/2020
3	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2020
3	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2019
3	CalreticulinIBA 07/2019 - 09/2018
2	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 01/2021
2	PlatinumIBA 02/2024 - 01/2019
2	Indicators and Reagents (Reagents)IBA 12/2023 - 02/2010
2	CollagenIBA 11/2023 - 03/2012
2	CytokinesIBA 07/2023 - 01/2022
2	UbiquitinIBA 07/2023 - 03/2018
2	Transaminases (Aminotransferases)IBA 07/2023 - 09/2009
2	AcidsIBA 01/2023 - 02/2022
2	VimentinIBA 01/2023 - 01/2014
2	Retinaldehyde (Retinal)IBA 01/2023 - 11/2022
2	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2022
2	CateninsIBA 01/2023 - 03/2012
2	Hematoxylin (Haematoxylon)IBA 11/2022 - 11/2019
2	Eosine Yellowish-(YS) (Eosin)IBA 11/2022 - 11/2019
2	DisulfidesIBA 10/2022 - 12/2020
2	Cysteine (L-Cysteine)FDA Link 10/2022 - 12/2020
2	Phosphotransferases (Kinase)IBA 10/2022 - 01/2018
2	NucleotidesIBA 01/2022 - 07/2019
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2017
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
2	Endoplasmic Reticulum Chaperone BiPIBA 01/2020 - 09/2011
2	ClaudinsIBA 12/2018 - 01/2018
2	Cadherins (E-Cadherin)IBA 01/2018 - 09/2011
1	Voltage-Gated Sodium ChannelsIBA 05/2024
1	Toll-Like Receptor 4IBA 05/2024
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 05/2024
1	Lactic Acid (Lactate)FDA LinkGeneric 04/2024
1	ChemokinesIBA 03/2024
1	Antiviral Agents (Antivirals)IBA 03/2024
1	AntigensIBA 03/2024
1	puerarinIBA 09/2023
1	ChromatinIBA 07/2023
1	Ligases (Synthetase)IBA 07/2023
1	TransferasesIBA 07/2023
1	TOR Serine-Threonine KinasesIBA 03/2023
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 03/2023
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 03/2023
1	Caspase 9IBA 03/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2023
1	Immunoconjugates (Immunoconjugate)IBA 01/2023
1	Chloride Channels (Chloride Channel)IBA 01/2023
1	Lamin Type A (Lamin A)IBA 01/2023
1	Olanzapine (Zyprexa)FDA Link 01/2023
1	Threonine (L-Threonine)FDA Link 01/2023
1	Antipsychotic Agents (Antipsychotics)IBA 01/2023

Therapy/Procedure

9	Therapeutics 03/2024 - 01/2011
8	Immunotherapy 11/2023 - 01/2020
4	Radiotherapy 03/2023 - 05/2017
3	Adjuvant Chemotherapy 02/2024 - 05/2017
2	Drug Therapy (Chemotherapy) 01/2023 - 02/2022
2	Hysterectomy 03/2018 - 01/2015